Skip to main content
OpenTrials
Completed

NCT Number: NCT02008604

Influence of Stroke on the Composition of Intestinal Microbiota

The aim of the study is to verify the hypothesis that the microbial colonisation of the gut is changed in patients after stroke and that the gut microbiome of severely affected stroke patients differs from that of patients with only a short disruption of blood circulation in the brain (transient ischemic attack, TIA). For this, the composition of gut microbiota in stool samples will be analyzed by 454 pyrosequencing. Further, the correlation of stroke-associated changes in the microbiome with immunological parameters will be analyzed.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age: 18 and older
  • ischemic cerebral infarction within the last 40 hours, anterior circulation infarct (ACA, MCA) and/or posterior circulation infarct (PCA, BA) of any severity
  • patient consent or consent by a legal representative
  • NIHSS > or =9 (stroke patients)
  • NIHSS < 1 (for TIA patients)

Exclusion criteria

  • intracranial hemorrhage
  • preexisting dysphagia
  • signs of infection upon admission (clinical/paraclinical)
  • existing antibiotic therapy upon admission or within the last 2 weeks before admission
  • mechanical ventilation upon admission
  • participation in an interventional therapy study

Treatment and study plan

Primary outcomes

  1. composition of intestinal microbiome

    Time frame: change between day 1, day 4, day 7, day 14 after stroke

    The composition of the intestinal metagenome / microbiome will be determined by analyzing the 16S rRNA by 454 Pyrosequencing.

Secondary outcomes

  1. test of correlation between most changed group of bacteria with changes in immunological parameters (HLA-DR)

    Time frame: days 1, 4, 7 after stroke

    Analysis of correlation between changes in microbiome (most changed group of bacteria, e.g. lactobacilli) with changes in immunological parameters (e.g. HLA-DR, IL-6, IL-10, CD4-lymphocytes from blood samples).

Sponsors and collaborators

Lead sponsor

Charite University, Berlin, Germany

Other

Collaborators

  • Dr. Christian Meisel, Medical Immunology, Charité Berlin, Germany
  • NeuroCure Clinical Research Center, Charite, Berlin
  • PD Dr. Andreas Nitsche, Robert-Koch-Institut, Berlin, Germany
  • Prof. Dr. Ulrich Dirnagl, Experimental Neurology, Charité Berlin, Germany

Registry information

Official study title

Influence of Stroke on the Composition of Intestinal Microbiota (GUTSTROKE)

Acronym: GUTSTROKE

Important dates

Study start
2014
Primary completion
2018
Study completion
2018
First posted
Dec 11, 2013
Registry last updated
Nov 29, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.